Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Since their introduction in clinical practice in the 1950′s, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of the...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, A H Aamir, Abbas Raza, A K Das, A K Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin, Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, S V Madhu, Tofail Ahmed, Uditha Bulughapitiya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Anti-hyperglycaemic agent
gliclazide
glimepiride
glipizide
safety
sulfonylurea
type 2 diabetes mellitus
vascular complications
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=5;spage=577;epage=596;aulast=Kalra

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=5;spage=577;epage=596;aulast=Kalra

Similar Items